Red Eye Investing

 But I’m not waving a white flag — because sometimes a drop reveals opportunity, not failure. 📌 The question: “Is this slump meaningful, or has the market over-corrected?” Based on the latest numbers, my view is that Novo Nordisk is fairly valued to slightly undervalued — meaning I’m comfortable holding and believe there’s potential upside, but this isn’t a free-lunch scenario. Staying focused, tracking the story, and playing the long game. #Investing #HealthCare #ValueMindset Valuation Snapshot & Commentary Here are the key points on Novo Nordisk’s valuation and risks: Positive signals (supporting undervaluation/hold): Trailing P/E is around ~14.3× and the forward P/E ~14.3-15× in many estimates. StockAnalysis +2 StockAnalysis +2 The company has a strong market position in diabetes and obesity treatments (e.g., drugs like Ozempic and Wegovy) and global scale. Morningstar +1 Caution/overhangs (why it might not be cheap): Novo Nordisk recently cut its full-...

 Holding a business that’s executing rather than cheering short-term hype. 📌 But: “Is it still undervalued, or has the market already run ahead?” Based on current metrics and growth trajectory, my view is that Blue Bird is slightly undervalued — meaning I’m comfortable holding, believe there’s still upside — but I’m also realistic that some of the upside has already been baked in. Patience + seeing the bus roll (literally) = the combo. #Investing #ValueMindset #IndustrialGrowth Valuation Snapshot & Commentary Blue Bird’s current P/E is ~15-16× according to Simply Wall St. Simply Wall St +2 Simply Wall St +2 That P/E is below its peers in the machinery/industrial sector (peer avg ~17-18×) and below the industry average (~24×) per one analysis. Simply Wall St Intrinsic / DCF valuation models: One gives a fair value around US$66.82 vs current ~$55-60, suggesting ~20% upside. Value Investing +1 Company fundamentals: Strong recent results — in 2024 revenue gre...

 But I’m not panicking — because sometimes a dip is simply the market’s fear, not the business failing. 📌 The question: “Is this a bargain… or a sign of trouble ahead?” Based on the latest numbers, I believe QFIN is undervalued , meaning this downside may represent an opportunity — but with a caveat: it’s not without risks. Sitting tight, watching updates, and believing in the long-term play. #Investing #Contrarian #ValueHunt Valuation Snapshot & Commentary Here are some key highlights for QFIN: What looks good (undervaluation signs): QFIN’s P/E ratio is very low — around ~3-4× earnings in certain reports, which is far below typical consumer finance or fintech peers. Simply Wall St +2 StockAnalysis +2 Some fair-value models put its value much higher (for example one model estimated fair value around US$117 compared to current ~US$25). Simply Wall St +1 It appears financially healthy: metrics like debt/equity are low, margins are strong in analyses, etc. ChartM...

 Holding a great business, long term mindset. 📌 But: “Is it still undervalued, or has the market got ahead of itself?” Based on the latest metrics and growth trajectory, my view is that Alphabet is fairly valued to slightly overvalued — meaning I’m comfortable holding (since this isn’t a panic situation), but I’m not expecting huge upside from a valuation rerate alone. Patience + execution = the winning combo. #Investing #LongTerm #TechGrowth Valuation Snapshot & Commentary Alphabet’s trailing P/E ≈ ≈ 26.9× and forward P/E ≈ 25.5×. GuruFocus +3 StockAnalysis +3 Simply Wall St +3 One DCF-based intrinsic value model gives a fair value around US$218 vs current price ~US$253, implying it’s ~14% overvalued in that model. Value Investing Another site estimates fair value at ~US$246.79, saying the stock is slightly overvalued (current price ~US$253). Simply Wall St It trades at a P/E lower than many tech peers (peer average ~54× in one comparison) which suggests...

 Holding the business long-term rather than chasing the next “hot” trade. 📌 The question: Is Amazon still a bargain, or has the value run ahead of fundamentals? Based on recent valuation metrics, there’s a decent case that it’s slightly undervalued — meaning I’m comfortable staying invested, but I’m not expecting fireworks tomorrow. Patience and consistency: the quietly powerful combo. #Investing #LongTerm #ValueMindset Valuation snapshot & commentary: Many analysts estimate a 12-month price target for Amazon somewhere around US$260-270 , which implies ~20-25% upside from today’s price. Trefis +2 StockAnalysis +2 One intrinsic value model puts Amazon at about US$251 versus current ~US$213, suggesting ~18% upside. Value Investing On metrics: its trailing P/E (≈ 32x) is lower than many peers in the retail/tech space (peer average P/E ≈ 40x) — which argues in favour of relative value. Simply Wall St On the flip side: its valuation is still above the broader m...